Archives
-
Ions Improve CPP-Mediated Nucleic Acid Delivery
2026-10-01
The reference study shows that biocompatible ions can remodel cell-penetrating peptide–nucleic acid nanoparticles and improve productive intracellular delivery, with multivalent ions exerting stronger effects than monovalent ions. Its most important mechanistic implication is that improved delivery is linked primarily to endosomal escape rather than a major change in nanoparticle internalization.
-
Paclitaxel (Taxol) Workflows for Cancer Research
2026-09-30
Build reproducible Paclitaxel assays around microtubule stabilization, cell cycle arrest, apoptosis, and combination-response measurements. This practical guide connects Taxol dose finding with the multi-node PI3K/AKT/mTOR strategy reported in endometrial and breast cancer models.
-
iRhom2 in Olfaction: Receptor Regulation and Adaptation
2026-09-30
The reference study identifies iRhom2 as a distinctive regulator in olfactory sensory neurons and links its expression to odorant-receptor transcription and activity-dependent adaptation. Its combination of knockout analysis, transcriptomics, in situ localization, and an ectopic receptor model suggests that iRhom2/ADAM17 signaling may connect odor-induced receptor activity with feedback control of olfactory gene programs.
-
Ceruletide in Reliable Cell and Pancreatic Assays
2026-09-29
Learn how Ceruletide, SKU B8465, can support controlled CCK-receptor perturbation in viability, proliferation, pancreatic function research, and gastrointestinal physiology studies. This scenario-based guide covers peptide handling, assay controls, protocol design, interpretation, and practical supplier-selection criteria.
-
D-Luciferin: Designing Trustworthy BLI Readouts
2026-09-29
D-Luciferin potassium salt is more than a light-producing reagent: it is the chemical input of a measurement system whose output depends on enzyme activity, ATP, oxygen, delivery, and optical context. This guide connects substrate chemistry with rigorous in vivo bioluminescence imaging, reporter assays, and mechanistic interpretation.
-
WST-8 Glucose Uptake Assay Kit Guide
2026-09-28
The WST-8 Glucose Uptake Assay Kit is a non-radioactive glucose uptake assay that converts 2-deoxyglucose metabolism into a 450 nm colorimetric signal. Its stated 10–500 μM linear range supports quantitative cellular glucose metabolism assay workflows when cell number, treatment conditions, and assay controls are standardized.
-
GOB-38 in Elizabethkingia anophelis: Enzyme Profile
2026-09-28
The study characterizes GOB-38, a metallo-β-lactamase variant from Elizabethkingia anophelis, and reports activity across penicillins, cephalosporins, and carbapenems. Its recombinant-enzyme and co-culture work connects substrate specificity with possible resistance implications, while leaving the scale and mechanism of resistance transfer to be established.
-
Mycophenolic acid in immune metabolism assays
2026-09-27
Use Mycophenolic acid to test how disrupting nucleotide biosynthesis changes stimulated immune-cell responses in a whole-blood assay. This practical guide covers compound handling, controlled dose finding, cytokine readouts, and troubleshooting while separating workflow recommendations from published findings.
-
Ceruletide Workflows for Pancreatic Fibrosis Research
2026-09-26
Use Ceruletide to build controlled caerulein-based pancreatic injury models and investigate how injury connects to fibrosis, autophagy, and gastrointestinal function. This guide pairs practical peptide handling with readouts that help distinguish disease-model effects from direct receptor or cell-signaling mechanisms.
-
Doxorubicin and the Persister-State Opportunity
2026-09-25
Doxorubicin is a powerful DNA-damage benchmark—but surviving cells may reveal biology beyond initial cytotoxicity. Learn how to connect its established mechanism with persister-state lipidomic research while keeping the evidence and experimental claims in perspective.
-
RBMS1 Loss Rewires PD-L1 Stability in TNBC
2026-09-25
A 2022 study links the RNA-binding protein RBMS1 to PD-L1 stability in triple-negative breast cancer through regulation of B4GALT1 mRNA and PD-L1 glycosylation. The findings nominate RBMS1 as an immunoregulatory target and support testing its loss alongside cellular immunotherapies, while leaving clinical efficacy and broader transferability unresolved.
-
ICI 118,551 Hydrochloride: Evidence and Limits
2026-09-24
ICI 118,551 hydrochloride is a β2-adrenoceptor antagonist research compound, but the cited stroke study investigated esculetin, not ICI 118,551. The study supports an esculetin–CKLF1–neutrophil mechanism in its experimental models; it does not establish a role for ICI 118,551 in stroke treatment.
-
Azilsartan Medoxomil: AT1 Blockade in Hypertension
2026-09-24
This 2017 MiniReview connects azilsartan medoxomil’s sustained AT1-receptor binding with clinical evidence of blood-pressure reduction, while noting that improved cardiovascular outcomes have not been established. Its literature-search approach and discussion of pharmacokinetics offer useful context for designing receptor and hypertension studies, but the findings should be interpreted as a narrative synthesis rather than a new trial or meta-analysis.
-
Hydrocortisone Butyrate for Reliable Cell Assays
2026-09-23
A practical guide to using Hydrocortisone butyrate (Hydrocortisone 17-butyrate), SKU N2898, in cell-based inflammation and viability workflows. It covers concentration selection, handling, interpretation of delivery-study data, and evidence-based product evaluation without assuming undocumented assay performance.
-
DIDS: Workflows for Chloride and Tumor Studies
2026-09-23
DIDS is a practical perturbation tool for connecting chloride transport, membrane signaling, vascular physiology, and cell-death biology. This guide translates its reported channel activity into controlled dose-response workflows and shows how the reference metastasis study can be tested without mistaking a broad pharmacological effect for target selectivity.